http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17384619

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
endingPage 421
issn 1387-2877
1875-8908
issueIdentifier 2
pageRange 405-421
publicationName Journal of Alzheimer's disease : JAD
startingPage 405
bibliographicCitation von Bernhardi R. Immunotherapy in Alzheimer's disease: where do we stand? Where should we go? J Alzheimers Dis. 2010;19(2):405–21. doi: 10.3233/jad-2010-1248. PMID: 20110590.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4960fa9cfc0a943241fac6f59783ab3
date 2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20110590
https://doi.org/10.3233/jad-2010-1248
isPartOf https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7568
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID2675

Total number of triples: 25.